For emerging pharmaceutical companies, moving a new product from development to commercial scale requires more than a technically effective sterilization process—it requires a partner who can navigate validation, documentation, timelines, and regulatory expectations. This case study explores how Pinnacle Therapeutics partnered with a bio-pharmaceutical startup to overcome complex terminal sterilization challenges and establish a reliable gamma sterilization pathway supporting commercialization and global market readiness.